These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 4892857

  • 41. [Antilymphocyte serum: clinical results obtained in renal transplantation by the use of antilymphocyte globulins].
    Traeger J, Perrin J, Fries D, Carraz M, Saubier E, Bonnet P, Archimbaud JP, Bernhardt JP, Brochier J, Betuel H, Veyssere C, Bryon PA, Prévot J.
    Presse Med (1893); 1968 Jul 13; 76(30):1517-20. PubMed ID: 4879618
    [No Abstract] [Full Text] [Related]

  • 42. [Anti-lymphocyte serum. 1. Specificity of rabbit immune serum against mouse thymocytes].
    Yamana S.
    Arerugi; 1969 Sep 13; 18(9):731-41. PubMed ID: 4902124
    [No Abstract] [Full Text] [Related]

  • 43. [Surprising results of intravenous therapy using antilymphocyte serum in organ transplantations].
    Brendel W, Land W.
    Dtsch Med Wochenschr; 1968 Nov 29; 93(48):2309-13. PubMed ID: 4880266
    [No Abstract] [Full Text] [Related]

  • 44. Use of antithymocyte globulin in human heart transplantation.
    Griepp RB, Stinson EB, Dong E, Phillips RC, Morrell RM, Shumway NE.
    Circulation; 1972 May 29; 45(5 Suppl 1):I147-53. PubMed ID: 4554349
    [No Abstract] [Full Text] [Related]

  • 45. Antilymphocyte serum: summary and further observations.
    Woodruff MF.
    Transplantation; 1967 Jul 29; 5(4):Suppl:1127-33. PubMed ID: 4860606
    [No Abstract] [Full Text] [Related]

  • 46. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I, Wolf JS, Wren SF, MacLean LD, Hume DM.
    Transplant Proc; 1973 Mar 29; 5(1):533-4. PubMed ID: 4572113
    [No Abstract] [Full Text] [Related]

  • 47. Preparation of an effective heterologous anti-lymphocyte serum for use in the dog.
    Atai M, Kelly WD.
    Surg Forum; 1966 Mar 29; 17():249-51. PubMed ID: 5331815
    [No Abstract] [Full Text] [Related]

  • 48. The place of heterologous antilymphocytic globulin in renal transplantation.
    Clunie GJ.
    Med J Aust; 1969 Jun 28; 1(26):1368-70. PubMed ID: 4898052
    [No Abstract] [Full Text] [Related]

  • 49. [Biological bases and progress in kidney transplantation. I. Immunological and histological reactions].
    Kirchheim D.
    Urologe; 1967 Jan 28; 6(1):1-13. PubMed ID: 4869790
    [No Abstract] [Full Text] [Related]

  • 50. Permanent survival of dog renal allografts after a limited course of antilymphocyte serum treatment.
    Shanfield I, Wren SF, Blennerhassett JB.
    Surg Forum; 1969 Jan 28; 20():304-5. PubMed ID: 4910606
    [No Abstract] [Full Text] [Related]

  • 51. [Present status of anti-lymphocyte serum and its problems].
    Fujimoto Y.
    Geka Chiryo; 1969 Jul 28; 21(1):86-91. PubMed ID: 4901874
    [No Abstract] [Full Text] [Related]

  • 52. Depletion of lymphocytes for the protection of renal allografts.
    Sarles HE, Remmers AR, Fish JC, Canales CO, Thomas FD, Tyson KR, Beathard GA, Ritzmann SE.
    Arch Intern Med; 1970 Mar 28; 125(3):443-50. PubMed ID: 4190497
    [No Abstract] [Full Text] [Related]

  • 53. Survival of canine renal allografts after antilymphocytic serum and bone-marrow treatment.
    Caridis DT, Lieogeois A, Barret I, Lytle BW, Monaco AP.
    Br J Surg; 1972 Apr 28; 59(4):311. PubMed ID: 4553597
    [No Abstract] [Full Text] [Related]

  • 54. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].
    Pichlmayr R, Brendel W, Pichlmayr I.
    Z Gesamte Exp Med Einschl Exp Chir; 1967 Apr 28; 143(3):313-9. PubMed ID: 4969335
    [No Abstract] [Full Text] [Related]

  • 55. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera.
    Balner H, Dersjant H, van Bekkum DW.
    Transplant Proc; 1969 Mar 28; 1(1):629-37. PubMed ID: 5002666
    [No Abstract] [Full Text] [Related]

  • 56. Suppression of canine renal allograft rejection with antilymphocyte serum.
    Clunie GJ, Howard RR, Robinson E, Morton H.
    Aust N Z J Surg; 1969 Aug 28; 39(1):68-71. PubMed ID: 4898557
    [No Abstract] [Full Text] [Related]

  • 57. Effect of antilymphocyte serum on the thymus.
    Levey RH, Taub R.
    Transplant Proc; 1969 Mar 28; 1(1):424-8. PubMed ID: 4944253
    [No Abstract] [Full Text] [Related]

  • 58. [Preparation, properties and activities of a horse anti-human lymphocyte serum].
    Traeger J, Carraz M, Fries D, Perrin J, Saubier E, Brochier J, Bernhardt JP, Archimbaud JP, Bonnet P, Veyssere C, Prevot R, Traeger-Fouillet Y, Bryon PA, Manuel Y.
    Pathol Biol; 1968 Jan 28; 16(1):27-39. PubMed ID: 4869418
    [No Abstract] [Full Text] [Related]

  • 59. [Toxicity and secondary effects of antilymphocyte serums].
    Dormont J, Josso F, Hors J, Jungers P, Bach JF.
    J Urol Nephrol (Paris); 1969 Sep 28; 75(9):589-93. PubMed ID: 4103959
    [No Abstract] [Full Text] [Related]

  • 60. Studies on heterologous antilymphocyte and antithymocyte sera. II. Effects on cellular antibody production during the early primary and secondary immune response of mice to sheep erythrocytes.
    Barth RF, Southworth J.
    J Immunol; 1968 Dec 28; 101(6):1283-90. PubMed ID: 5722464
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.